{"response": {"meta": {"time": 18, "hits": 4, "offset": 0}, "docs": [{"news_desk": "National Desk", "document_type": "article", "_id": "4fd2142a8eb7c8105d78bd55", "headline": {"main": "Americans Becoming Lax About High Blood Pressure"}, "pub_date": "1997-11-07T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By LAWRENCE K. ALTMAN", "person": [{"middlename": "K.", "organization": "", "role": "reported", "rank": 1, "firstname": "Lawrence", "lastname": "ALTMAN"}]}, "abstract": "Federal health officials report that, in surprising reversal of longtime health gains, fewer adult Americans are aware they have high blood pressure, fewer are getting effective therapy, and more are dying as a result; suspected factors could be increase in obesity, complacency among doctors and patients, patients who stop taking drugs and lack of effective communication to public; Dr Claude Lenfant and Dr Edward J Roccella of National Heart, Lung and Blood Institute lay out efforts to improve compliance with therapy; new guidelines are issued on weight loss, excercise and low-fat diet (M)", "web_url": "http://www.nytimes.com/1997/11/07/us/americans-becoming-lax-about-high-blood-pressure.html", "section_name": "Health; U.S.", "lead_paragraph": "In a surprising reversal of longtime health gains, fewer adult Americans are aware they have high blood pressure, fewer are getting effective therapy, and more are dying as a result, Federal health officials said here today in issuing new treatment guidelines for the ailment, which affects 50 million Americans. Over the last 25 years, therapies to fight high blood pressure have led to significant declines in deaths from stroke and coronary heart disease. But the latest health statistics show a rise in severe kidney disease and heart failure, a slight rise in the rate of stroke, and a leveling in the death rate for Americans with coronary heart disease. These conditions often occur as complications of longstanding high blood pressure, which is also called hypertension.", "snippet": "In a surprising reversal of longtime health gains, fewer adult Americans are aware they have high blood pressure, fewer are getting effective therapy, and more are dying as a result, Federal health officials said here today in issuing new treatment...", "blog": [], "keywords": [{"value": "LENFANT, CLAUDE", "name": "persons"}, {"value": "ROCCELLA, EDWARD J", "name": "persons"}, {"value": "NATIONAL HEART, LUNG AND BLOOD INSTITUTE", "name": "organizations"}, {"value": "DIET AND NUTRITION", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "STANDARDS AND STANDARDIZATION", "name": "subject"}, {"value": "EXERCISE", "name": "subject"}, {"value": "BLOOD PRESSURE", "name": "subject"}], "print_page": "14", "type_of_material": "News", "word_count": 963, "subsection_name": null, "multimedia": []}, {"news_desk": "National Desk", "document_type": "article", "_id": "4fd2156b8eb7c8105d78eacf", "headline": {"main": "F.D.A. Warns About Herbs for Weight Loss"}, "pub_date": "1997-11-07T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By SHERYL GAY STOLBERG", "person": [{"middlename": "Gay", "organization": "", "role": "reported", "rank": 1, "firstname": "Sheryl", "lastname": "STOLBERG"}]}, "abstract": "FDA warns consumers about potential dangers of herbal weight loss cocktails; also threatens legal action against maker of 'Herbal Phen-Fen' for making false, illegal claims; orders company to stop using phen-fen in its name, noting it contains neither phentermine nor fenfluramine; product contains St John's Wort and ephedra, natural stimulant that Acting Comr Michael A Friedman warns can be harmful; HPF LLC refuses to disclose its ownership or link to Nutri-System weight loss clinics (S)", "web_url": "http://www.nytimes.com/1997/11/07/us/fda-warns-about-herbs-for-weight-loss.html", "section_name": "Health; U.S.", "lead_paragraph": "Two months after it forced the popular diet drug combination known as fen-phen off the market, the Food and Drug Administration today issued a consumer warning about the possible dangers of herbal weight loss cocktails, which are widely available in diet clinics and health food stores and over the Internet. The F.D.A. also threatened legal action against the manufacturer of ''Herbal Phen-Fen,'' the most popular of these alternatives. The agency accused the company of making false and illegal claims that its product promotes weight loss, and ordered it to stop using phen-fen in its name.", "snippet": "Two months after it forced the popular diet drug combination known as fen-phen off the market, the Food and Drug Administration today issued a consumer warning about the possible dangers of herbal weight loss cocktails, which are widely available in...", "blog": [], "keywords": [{"value": "FRIEDMAN, MICHAEL A", "name": "persons"}, {"value": "FOOD AND DRUG ADMINISTRATION", "name": "organizations"}, {"value": "HPF LLC", "name": "organizations"}, {"value": "NUTRI-SYSTEM INC", "name": "organizations"}, {"value": "EPHEDRA (HERB)", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "ADVERTISING", "name": "subject"}, {"value": "MISLEADING AND DECEPTIVE ADVERTISING", "name": "subject"}, {"value": "DIETING", "name": "subject"}, {"value": "HERBS", "name": "subject"}, {"value": "ST JOHN'S WORT (HERB)", "name": "subject"}, {"value": "LABELING AND LABELS", "name": "subject"}, {"value": "PHENTERMINE (DRUG)", "name": "subject"}, {"value": "CONSUMER PROTECTION", "name": "subject"}, {"value": "FENFLURAMINE (DRUG)", "name": "subject"}], "print_page": "19", "type_of_material": "News", "word_count": 518, "subsection_name": null, "multimedia": []}, {"news_desk": "National Desk", "document_type": "article", "_id": "4fd2156c8eb7c8105d78eb0b", "headline": {"main": "Study Finds Big Weight Gain Raises Risk of Breast Cancer"}, "pub_date": "1997-11-05T00:00:00Z", "slideshow_credits": null, "source": "AP", "byline": null, "abstract": "Study of more than 95,000 nurses provides evidence that women who gain significant amount of weight after age 18 have substantial increase in risk of breast cancer; likely reason is that body fat increases amount of estrogen in bloodstream; women who had gained at least 45 pounds were twice as likely to develop spreading breast cancer as women with almost no weight gain; lead author Dr Zhiping Huang adds that blood estrogen is derived largely from body fat after menopause (S)", "web_url": "http://www.nytimes.com/1997/11/05/us/study-finds-big-weight-gain-raises-risk-of-breast-cancer.html", "section_name": null, "lead_paragraph": "A study of more than 95,000 nurses provides what may be the strongest evidence yet that women who put on a lot of weight during adulthood raise their risk of breast cancer substantially. Researchers said a likely reason was that body fat increased the amount of estrogen in the bloodstream. And estrogen is thought to promote breast tumors.", "snippet": "A study of more than 95,000 nurses provides what may be the strongest evidence yet that women who put on a lot of weight during adulthood raise their risk of breast cancer substantially.    Researchers said a likely reason was that body fat increased...", "blog": [], "keywords": [{"value": "HUANG, ZHIPING", "name": "persons"}, {"value": "ESTROGEN", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "BREAST", "name": "subject"}, {"value": "CANCER", "name": "subject"}, {"value": "WOMEN", "name": "subject"}], "print_page": "12", "type_of_material": "News", "word_count": "416", "subsection_name": null, "multimedia": []}, {"news_desk": "Business/Financial Desk", "document_type": "article", "_id": "4fd1f72a8eb7c8105d752285", "headline": {"main": "A Prescription To Keep P.& G. Growing Strong; Big Household Name Tries To Be a Drugstore Hit, Too"}, "pub_date": "1997-11-04T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By DANA CANEDY", "person": [{"lastname": "CANEDY", "rank": 1, "firstname": "Dana", "organization": "", "role": "reported"}]}, "abstract": "Procter & Gamble Co, nation's leading producer of household products, is aggressively trying to move into prescription pharmaceuticals business, where profit margins for successful drugs can be more than double those for some its current products; P&G has huge presence on supermarket shelves, but it is barely known in doctors' offices and health insurance companies, and it lacks track record and product range to command credibility it would need in prescription drug business; despite this, P&G executives see opportunities in developing drugs for aging population; in drug industry, challenge in staying ahead of innovation curve underscores difficulty P&G will have reaping kind of returns it is counting on from its drug division; Wall Street has shown mixed reaction to P&G's new effort; photos; charts (L)", "web_url": "http://www.nytimes.com/1997/11/04/business/prescription-keep-p-g-growing-strong-big-household-name-tries-be-drugstore-hit.html", "section_name": "Health; Business", "lead_paragraph": "The Procter & Gamble Company is so obsessed with outdoing the competition that its executives have been known to peek into friends' closets to make sure they are not stocking rival brands of soap, dishwashing liquid and shampoo. Now, though, P.& G. is no longer satisfied simply controlling what goes into kitchen cabinets and shower stalls. It also wants more space in consumers' medicine chests, and not just for toothpaste.", "snippet": "The Procter & Gamble Company is so obsessed with outdoing the competition that its executives have been known to peek into friends' closets to make sure they are not stocking rival brands of soap, dishwashing liquid and shampoo.    Now, though, P.&...", "blog": [], "keywords": [{"value": "PROCTER & GAMBLE CO", "name": "organizations"}, {"value": "COMPANY AND ORGANIZATION PROFILES", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1406, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}